Jagsonpal Pharmaceuticals

240.99
+1.68
(0.70%)
Market Cap
1,599.86 Cr
EPS
8.49
PE Ratio
43.57
Dividend Yield
0.83 %
Industry
Healthcare
52 Week High
328.04
52 Week Low
110.00
PB Ratio
8.06
Debt to Equity
0.04
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,787.40
#1 4,28,857.13
36.71
#1 49,887.20
12.06
#1 9,648
13.77
59.27
6,012.50
1,59,612.98
79.83
8,184.00
0.89
1,600
#1 64.53
57.99
1,525.90
1,23,233.96
25.11
26,520.70
14.17
4,155
47.38
57.43
3,238.90
1,09,619.09
60.42
10,785.70
11.59
1,656
13.54
52.37
2,557.50
1,05,516.96
52.60
10,615.60
19.57
1,942
-16.38
59.98
1,174.80
98,031.82
#1 18.66
28,905.40
12.36
5,578
1.69
54.12
2,019.60
92,203.01
33.50
20,141.50
#1 19.94
1,936
38.82
50.28
859.65
86,500.90
19.53
19,831.50
13.82
3,831
29.92
46.44
1,220.10
70,863.61
20.72
29,559.20
17.55
3,169
-10.04
58.85
29,705.00
63,121.05
47.82
6,097.20
10.80
1,201
16.01
45.94
Growth Rate
Revenue Growth
-10.07 %
Net Income Growth
-15.73 %
Cash Flow Change
-24.62 %
ROE
-28.72 %
ROCE
-26.33 %
EBITDA Margin (Avg.)
-9.79 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
138
144
144
127
168
161
192
221
242
218
285
Expenses
129
132
138
138
158
150
169
193
203
186
212
EBITDA
9
13
6
-11
11
11
24
29
40
32
73
Operating Profit %
6 %
8 %
4 %
-9 %
6 %
5 %
10 %
12 %
14 %
11 %
15 %
Depreciation
3
3
2
0
1
1
1
2
1
2
6
Interest
5
5
3
1
1
1
1
0
0
1
1
Profit Before Tax
2
4
14
-12
9
9
22
27
35
30
66
Tax
1
1
3
-0
2
2
5
8
8
7
13
Net Profit
1
3
12
-12
7
8
17
19
27
23
52
EPS in ₹
0.45
1.24
4.53
-4.41
2.75
3.00
6.51
7.20
10.20
8.49
12.30

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
154
159
143
130
136
147
164
164
195
217
Fixed Assets
52
52
22
21
22
22
26
23
24
9
Current Assets
96
101
110
95
98
95
121
109
165
199
Capital Work in Progress
0
0
0
3
4
4
0
0
0
0
Investments
0
0
0
0
0
11
15
51
1
0
Other Assets
102
108
121
106
110
109
123
91
170
208
Total Liabilities
154
159
143
130
136
147
164
164
195
217
Current Liabilities
55
57
29
29
28
33
40
27
28
19
Non Current Liabilities
4
4
3
3
3
3
2
5
9
11
Total Equity
95
98
110
98
105
111
122
133
159
187
Reserve & Surplus
82
85
97
85
91
98
109
120
146
174
Share Capital
13
13
13
13
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
2
1
5
-6
24
-1
19
-36
-12
2
Investing Activities
-1
-2
41
-3
-1
-11
-2
-26
-58
-25
Operating Activities
4
9
-3
-2
31
11
28
7
47
35
Financing Activities
-1
-6
-34
-1
-6
-1
-7
-18
-1
-9

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
70.34 %
70.34 %
70.34 %
70.34 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.48 %
68.09 %
68.04 %
67.97 %
67.81 %
67.78 %
FIIs
0.00 %
0.00 %
0.11 %
0.20 %
0.00 %
0.00 %
0.13 %
0.00 %
0.00 %
0.00 %
0.38 %
0.00 %
0.73 %
1.10 %
2.30 %
2.10 %
2.10 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.28 %
0.77 %
0.83 %
0.83 %
0.83 %
0.00 %
0.85 %
0.85 %
0.11 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.67 %
26.08 %
23.71 %
23.71 %
22.92 %
25.27 %
22.78 %
21.11 %
22.23 %
22.84 %
21.99 %
21.94 %
20.69 %
20.79 %
20.38 %
20.64 %
20.94 %
Others
2.98 %
3.57 %
5.83 %
5.75 %
8.36 %
6.02 %
8.10 %
9.40 %
8.23 %
7.62 %
8.09 %
9.58 %
9.64 %
9.22 %
9.24 %
9.45 %
9.17 %
No of Share Holders
0
12,546
14,655
14,353
20,031
17,100
16,194
14,952
14,084
13,782
16,041
15,785
16,282
15,748
15,633
18,471
21,085

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.1 0.1 0.1 0.25 0.5 1 4 5 5 0.00
Dividend Yield (%) 0.66 0.93 0.95 3.56 1.57 0.8 3.45 4.52 2.3 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS6 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 02, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 02, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 13, 2025
Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Mar 13, 2025
Appointment of Company Secretary and Compliance OfficerMar 13, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 03, 2025
Clarification In Reference To The Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 Dated February 21 2025Feb 27, 2025
Clarification In Reference To The Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 Dated February 21 2025Feb 27, 2025
Announcement under Regulation 30 (LODR)-AcquisitionFeb 21, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR)Feb 21, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 17, 2025
Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR)Feb 05, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 05, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 23, 2025
Integrated Filing (Financial)Jan 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 22, 2025
Outcome Of Board Meeting Held On January 22 2025 To Consider And Approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 22, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On January 22 2025 To Consider And Approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 15, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 03, 2025
Closure of Trading WindowDec 30, 2024
Intimation For Record Date For Sub- Division/Split Of Equity Shares Of The CompanyDec 17, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportDec 12, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 06, 2024
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Nov 22, 2024
Update On Intimation As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Sale Of Company''s Faridabad FacilityNov 19, 2024
Announcement Under Regulation 30 - Outcome Of Analyst/Investor MeetNov 12, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 12, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 11, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 05, 2024
Announcement Under Regulation 30 - Outcome Of Analyst/Investor MeetNov 04, 2024
Announcement Under Regulation 30 - Outcome Of Analyst/Investor MeetNov 04, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptOct 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 24, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 24, 2024
Related Party Transaction For The Half Year Ended September 30, 2024Oct 23, 2024
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationOct 23, 2024
Corporate Action-Intimation of Sub division / Stock SplitOct 23, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 23, 2024
Outcome Of Board Meeting Held On October 23, 2024 & Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements Regulations, 2015Oct 23, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On October 23, 2024 & Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements Regulations, 2015Oct 23, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 16, 2024

Technical Indicators

RSI(14)
Neutral
62.01
ATR(14)
Volatile
14.16
STOCH(9,6)
Neutral
72.39
STOCH RSI(14)
Overbought
89.88
MACD(12,26)
Bullish
3.00
ADX(14)
Weak Trend
16.53
UO(9)
Bearish
43.11
ROC(12)
Uptrend And Accelerating
11.66
WillR(14)
Neutral
-35.08